Treatment of basal cell carcinoma with curettage alone - 09/08/11
Correspondence to: Katherine K. Lim, MD, Department of Dermatology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259.Scottsdale, Arizona
Abstract |
Background |
Although curettage and electrodesiccation (C&E) is widely used to treat basal cell carcinoma, whether electrodesiccation improves outcome is unknown.
Objective |
We sought to compare cure rates of curettage alone with those of C&E.
Methods |
We conducted a retrospective records review of patients treated with curettage alone at 5-year follow-up or longer that extracted data about tumor location, size, histologic subtype, biopsy specimen margin involvement, and recurrence, as well as data about the medical history of patients treated in a dermatology clinic in a tertiary-care academic medical institution.
Results |
Biopsy-proven tumors (302) amenable to treatment with C&E and treated by a single investigator with curettage alone had a 5-year cure rate of 96.03%, with minimal complications (hypopigmentation, scarring). Tumors involving more than 50% of the deep edge of the shave biopsy specimen had an increased risk of recurrence.
Limitations |
This is a retrospective study based on historic controls.
Conclusion |
For nonaggressive basal cell carcinoma, curettage alone has a cure rate similar to the published rates for C&E.
Le texte complet de cet article est disponible en PDF.Plan
| Drs Zalla and Kyle are currently in private practice in Florence, Ky, and Torrance, Calif, respectively. Funding sources: None. Conflicts of interest: None identified. Reprints not available from the authors. |
Vol 54 - N° 6
P. 1039-1045 - juin 2006 Retour au numéro
Article précédent
- Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy
- Stephen B. Tucker, Jerry W. Polasek, Anthony J. Perri, Elizabeth A. Goldsmith
- Infantile perineal protrusion
- Amor Khachemoune, Kjetil Kristoffer Guldbakke, Eric Ehrsam
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?